Industry: Chemical & Material
Published Date: 2026-03-05
Pages: 151 Pages
Report ld: 6008550
Request Sample
Customized Report
Peptide Nucleic Acid (PNA) Market Size(US$)

CAGR 2026-2032
14.3%
Market Size,2032
USD 987
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Peptide Nucleic Acid (PNA) market was valued at US$ 392 million in 2025 and is anticipated to reach US$ 987 million by 2032, at a CAGR of 14.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Peptide Nucleic Acid (PNA) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Peptide nucleic acid (PNA) is a synthetic polymer similar to DNA or RNA. Similar to polypeptides, various purine and pyrimidine bases are connected to the main chain skeleton through methylene carbonyl groups. Since PNA has no negative charge, there is no electrostatic repulsion between it and DNA and RNA, so the stability and specificity of the binding are greatly improved. It is not easily hydrolyzed by DNA enzymes and proteases, and PNA is extremely stable in vivo and in vitro.
Market drivers: With the rapid development of personalized medicine and precision medicine, PNA has shown great potential in the fields of genetic diagnosis, targeted therapy and drug delivery due to its high specificity and stability, which has driven market demand. PNA can be used as an auxiliary material for gene editing tools (such as CRISPR-Cas9) to enhance the efficiency and specificity of gene editing, benefiting from the widespread application of gene editing technology. The application of PNA in molecular diagnostic technologies (such as fluorescence in situ hybridization FISH and PCR) has become an important tool in the field of diagnosis due to its high binding affinity and stability. The policy support and financial investment of governments in precision medicine, gene therapy and biotechnology have created a favorable environment for the PNA market. The continuous improvement of PNA synthesis technology and modification methods has reduced production costs and improved application efficiency, further promoting market development.
Market risks: The synthesis and purification process of PNA is complex and costly, which may limit its large-scale production and commercial application. As a medical and diagnostic tool, PNA needs to pass strict regulatory approval (such as FDA, EMA), and the approval cycle is long and uncertain, which increases the difficulty of market access. The design, synthesis and application of PNA require highly specialized technology, which may limit its popularity in scientific research and clinical practice. PNA faces competition from other nucleic acid analogs (such as siRNA, antisense oligonucleotides) and gene editing technologies, which may affect its market share. PNA technology is relatively new, and market awareness and acceptance are low, which may affect its promotion and application. The supply chain of raw materials and reagents required for PNA production is unstable, which may affect production and delivery. The application of PNA in clinical practice is still in its early stages, and its safety, effectiveness and long-term effects need further verification.
This report delivers a comprehensive overview of the global Peptide Nucleic Acid (PNA) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Peptide Nucleic Acid (PNA). The Peptide Nucleic Acid (PNA) market size, estimates, and forecasts are provided in terms of output/shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Peptide Nucleic Acid (PNA) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Peptide Nucleic Acid (PNA) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Peptide Nucleic Acid (PNA) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Peptide Nucleic Acid (PNA) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Peptide Nucleic Acid (PNA) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Peptide Nucleic Acid (PNA) Market Overview
1.1 Product Definition
1.2 Peptide Nucleic Acid (PNA) by Type
1.2.1 Global Peptide Nucleic Acid (PNA) Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Labeled PNAs
1.2.3 Unlabeled PNAs
1.3 Peptide Nucleic Acid (PNA) by Application
1.3.1 Global Peptide Nucleic Acid (PNA) Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Gene Probes
1.3.3 Drug Development
1.3.4 Microarrays and Biosensors
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Peptide Nucleic Acid (PNA) Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Peptide Nucleic Acid (PNA) Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Peptide Nucleic Acid (PNA) Production Estimates and Forecasts (2021–2032)
1.4.4 Global Peptide Nucleic Acid (PNA) Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Peptide Nucleic Acid (PNA) Production Market Share by Manufacturers (2021–2026)
2.2 Global Peptide Nucleic Acid (PNA) Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Peptide Nucleic Acid (PNA), Industry Ranking, 2024 vs 2025
2.4 Global Peptide Nucleic Acid (PNA) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Peptide Nucleic Acid (PNA) Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Peptide Nucleic Acid (PNA), Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Peptide Nucleic Acid (PNA), Product Offerings and Applications
2.8 Global Key Manufacturers of Peptide Nucleic Acid (PNA), Date of Entry into the Industry
2.9 Peptide Nucleic Acid (PNA) Market Competitive Situation and Trends
2.9.1 Peptide Nucleic Acid (PNA) Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Peptide Nucleic Acid (PNA) Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Peptide Nucleic Acid (PNA) Production by Region
3.1 Global Peptide Nucleic Acid (PNA) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Peptide Nucleic Acid (PNA) Production Value by Region (2021–2032)
3.2.1 Global Peptide Nucleic Acid (PNA) Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Peptide Nucleic Acid (PNA) by Region (2027–2032)
3.3 Global Peptide Nucleic Acid (PNA) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Peptide Nucleic Acid (PNA) Production Volume by Region (2021–2032)
3.4.1 Global Peptide Nucleic Acid (PNA) Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Peptide Nucleic Acid (PNA) by Region (2027–2032)
3.5 Global Peptide Nucleic Acid (PNA) Market Price Analysis by Region (2021–2032)
3.6 Global Peptide Nucleic Acid (PNA) Production, Value, and Year-over-Year Growth
3.6.1 North America Peptide Nucleic Acid (PNA) Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Peptide Nucleic Acid (PNA) Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Peptide Nucleic Acid (PNA) Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Peptide Nucleic Acid (PNA) Production Value Estimates and Forecasts (2021–2032)
4 Peptide Nucleic Acid (PNA) Consumption by Region
4.1 Global Peptide Nucleic Acid (PNA) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Peptide Nucleic Acid (PNA) Consumption by Region (2021–2032)
4.2.1 Global Peptide Nucleic Acid (PNA) Consumption by Region (2021–2026)
4.2.2 Global Peptide Nucleic Acid (PNA) Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Peptide Nucleic Acid (PNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Peptide Nucleic Acid (PNA) Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Peptide Nucleic Acid (PNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Peptide Nucleic Acid (PNA) Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Peptide Nucleic Acid (PNA) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Peptide Nucleic Acid (PNA) Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Peptide Nucleic Acid (PNA) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Peptide Nucleic Acid (PNA) Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Peptide Nucleic Acid (PNA) Production by Type (2021–2032)
5.1.1 Global Peptide Nucleic Acid (PNA) Production by Type (2021–2026)
5.1.2 Global Peptide Nucleic Acid (PNA) Production by Type (2027–2032)
5.1.3 Global Peptide Nucleic Acid (PNA) Production Market Share by Type (2021–2032)
5.2 Global Peptide Nucleic Acid (PNA) Production Value by Type (2021–2032)
5.2.1 Global Peptide Nucleic Acid (PNA) Production Value by Type (2021–2026)
5.2.2 Global Peptide Nucleic Acid (PNA) Production Value by Type (2027–2032)
5.2.3 Global Peptide Nucleic Acid (PNA) Production Value Market Share by Type (2021–2032)
5.3 Global Peptide Nucleic Acid (PNA) Price by Type (2021–2032)
6 Segment by Application
6.1 Global Peptide Nucleic Acid (PNA) Production by Application (2021–2032)
6.1.1 Global Peptide Nucleic Acid (PNA) Production by Application (2021–2026)
6.1.2 Global Peptide Nucleic Acid (PNA) Production by Application (2027–2032)
6.1.3 Global Peptide Nucleic Acid (PNA) Production Market Share by Application (2021–2032)
6.2 Global Peptide Nucleic Acid (PNA) Production Value by Application (2021–2032)
6.2.1 Global Peptide Nucleic Acid (PNA) Production Value by Application (2021–2026)
6.2.2 Global Peptide Nucleic Acid (PNA) Production Value by Application (2027–2032)
6.2.3 Global Peptide Nucleic Acid (PNA) Production Value Market Share by Application (2021–2032)
6.3 Global Peptide Nucleic Acid (PNA) Price by Application (2021–2032)
7 Key Companies Profiled
7.1 SBS Genetech
7.1.1 SBS Genetech Peptide Nucleic Acid (PNA) Company Information
7.1.2 SBS Genetech Peptide Nucleic Acid (PNA) Product Portfolio
7.1.3 SBS Genetech Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 SBS Genetech Main Business and Markets Served
7.1.5 SBS Genetech Recent Developments/Updates
7.2 HLB panagene
7.2.1 HLB panagene Peptide Nucleic Acid (PNA) Company Information
7.2.2 HLB panagene Peptide Nucleic Acid (PNA) Product Portfolio
7.2.3 HLB panagene Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 HLB panagene Main Business and Markets Served
7.2.5 HLB panagene Recent Developments/Updates
7.3 LifeTein
7.3.1 LifeTein Peptide Nucleic Acid (PNA) Company Information
7.3.2 LifeTein Peptide Nucleic Acid (PNA) Product Portfolio
7.3.3 LifeTein Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 LifeTein Main Business and Markets Served
7.3.5 LifeTein Recent Developments/Updates
7.4 SB-PEPTIDE
7.4.1 SB-PEPTIDE Peptide Nucleic Acid (PNA) Company Information
7.4.2 SB-PEPTIDE Peptide Nucleic Acid (PNA) Product Portfolio
7.4.3 SB-PEPTIDE Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 SB-PEPTIDE Main Business and Markets Served
7.4.5 SB-PEPTIDE Recent Developments/Updates
7.5 LGC Biosearch Technologies
7.5.1 LGC Biosearch Technologies Peptide Nucleic Acid (PNA) Company Information
7.5.2 LGC Biosearch Technologies Peptide Nucleic Acid (PNA) Product Portfolio
7.5.3 LGC Biosearch Technologies Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 LGC Biosearch Technologies Main Business and Markets Served
7.5.5 LGC Biosearch Technologies Recent Developments/Updates
7.6 Creative Biogene
7.6.1 Creative Biogene Peptide Nucleic Acid (PNA) Company Information
7.6.2 Creative Biogene Peptide Nucleic Acid (PNA) Product Portfolio
7.6.3 Creative Biogene Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Creative Biogene Main Business and Markets Served
7.6.5 Creative Biogene Recent Developments/Updates
7.7 Creative Peptides
7.7.1 Creative Peptides Peptide Nucleic Acid (PNA) Company Information
7.7.2 Creative Peptides Peptide Nucleic Acid (PNA) Product Portfolio
7.7.3 Creative Peptides Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Creative Peptides Main Business and Markets Served
7.7.5 Creative Peptides Recent Developments/Updates
7.8 BOC Sciences
7.8.1 BOC Sciences Peptide Nucleic Acid (PNA) Company Information
7.8.2 BOC Sciences Peptide Nucleic Acid (PNA) Product Portfolio
7.8.3 BOC Sciences Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 BOC Sciences Main Business and Markets Served
7.8.5 BOC Sciences Recent Developments/Updates
7.9 PNA BIO INC
7.9.1 PNA BIO INC Peptide Nucleic Acid (PNA) Company Information
7.9.2 PNA BIO INC Peptide Nucleic Acid (PNA) Product Portfolio
7.9.3 PNA BIO INC Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 PNA BIO INC Main Business and Markets Served
7.9.5 PNA BIO INC Recent Developments/Updates
7.10 Bio-Synthesis Inc
7.10.1 Bio-Synthesis Inc Peptide Nucleic Acid (PNA) Company Information
7.10.2 Bio-Synthesis Inc Peptide Nucleic Acid (PNA) Product Portfolio
7.10.3 Bio-Synthesis Inc Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Bio-Synthesis Inc Main Business and Markets Served
7.10.5 Bio-Synthesis Inc Recent Developments/Updates
7.11 Biomers.net
7.11.1 Biomers.net Peptide Nucleic Acid (PNA) Company Information
7.11.2 Biomers.net Peptide Nucleic Acid (PNA) Product Portfolio
7.11.3 Biomers.net Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Biomers.net Main Business and Markets Served
7.11.5 Biomers.net Recent Developments/Updates
7.12 DESTINA Genomics
7.12.1 DESTINA Genomics Peptide Nucleic Acid (PNA) Company Information
7.12.2 DESTINA Genomics Peptide Nucleic Acid (PNA) Product Portfolio
7.12.3 DESTINA Genomics Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 DESTINA Genomics Main Business and Markets Served
7.12.5 DESTINA Genomics Recent Developments/Updates
7.13 FASMAC
7.13.1 FASMAC Peptide Nucleic Acid (PNA) Company Information
7.13.2 FASMAC Peptide Nucleic Acid (PNA) Product Portfolio
7.13.3 FASMAC Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 FASMAC Main Business and Markets Served
7.13.5 FASMAC Recent Developments/Updates
7.14 Allpeptide
7.14.1 Allpeptide Peptide Nucleic Acid (PNA) Company Information
7.14.2 Allpeptide Peptide Nucleic Acid (PNA) Product Portfolio
7.14.3 Allpeptide Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Allpeptide Main Business and Markets Served
7.14.5 Allpeptide Recent Developments/Updates
7.15 TAHE-PNA
7.15.1 TAHE-PNA Peptide Nucleic Acid (PNA) Company Information
7.15.2 TAHE-PNA Peptide Nucleic Acid (PNA) Product Portfolio
7.15.3 TAHE-PNA Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 TAHE-PNA Main Business and Markets Served
7.15.5 TAHE-PNA Recent Developments/Updates
7.16 QiYuebio
7.16.1 QiYuebio Peptide Nucleic Acid (PNA) Company Information
7.16.2 QiYuebio Peptide Nucleic Acid (PNA) Product Portfolio
7.16.3 QiYuebio Peptide Nucleic Acid (PNA) Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 QiYuebio Main Business and Markets Served
7.16.5 QiYuebio Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Peptide Nucleic Acid (PNA) Industry Chain Analysis
8.2 Peptide Nucleic Acid (PNA) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Peptide Nucleic Acid (PNA) Production Modes and Processes
8.4 Peptide Nucleic Acid (PNA) Sales and Marketing
8.4.1 Peptide Nucleic Acid (PNA) Sales Channels
8.4.2 Peptide Nucleic Acid (PNA) Distributors
8.5 Peptide Nucleic Acid (PNA) Customer Analysis
9 Peptide Nucleic Acid (PNA) Market Dynamics
9.1 Peptide Nucleic Acid (PNA) Industry Trends
9.2 Peptide Nucleic Acid (PNA) Market Drivers
9.3 Peptide Nucleic Acid (PNA) Market Challenges
9.4 Peptide Nucleic Acid (PNA) Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Peptide Nucleic Acid (PNA) market size was US$ 392 million in 2025 and is forecast to reach a readjusted size of US$ 987 million by 2032 with a CAGR of 14.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 104
USD 4250.00
(Single User License)
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 987 million by 2032, at a CAGR of 14.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 180
USD 4900.00
(Single User License)
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 392 million in 2025 and is projected to reach US$ 987 million, growing at a CAGR of 14.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 142
USD 3950.00
(Single User License)
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 364 million in 2024 to US$ 874 million by 2031, at a CAGR of 14.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 175
USD 4900.00
(Single User License)
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 874 million by 2031, at a Compound Annual Growth Rate (CAGR) of 14.3% during the forecast period.
Published Date: 2025-04-14
Pages: 179
USD 4900.00
(Single User License)
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 364 million in 2024 and is forecast to a readjusted size of US$ 874 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 141
USD 3950.00
(Single User License)
The global Peptide Nucleic Acid (PNA) market size was US$ 364 million in 2024 and is forecast to a readjusted size of US$ 874 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 102
USD 4250.00
(Single User License)
The global market for Peptide Nucleic Acid (PNA) was valued at US$ 364 million in the year 2024 and is projected to reach a revised size of US$ 874 million by 2031, growing at a CAGR of 14.3% during the forecast period.
Published Date: 2025-04-14
Pages: 106
USD 2900.00
(Single User License)
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published Date: 2024-10-25
Pages: 113
USD 2900.00
(Single User License)
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published Date: 2024-10-25
Pages: 146
USD 4350.00
(Single User License)
The global Peptide Nucleic Acid (PNA) market size was US$ 392 million in 2025 and is forecast to reach a readjusted size of US$ 987 million by 2032 with a CAGR of 14.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 104
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 987 million by 2032, at a CAGR of 14.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 180
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 392 million in 2025 and is projected to reach US$ 987 million, growing at a CAGR of 14.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 142
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 364 million in 2024 to US$ 874 million by 2031, at a CAGR of 14.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 175
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 874 million by 2031, at a Compound Annual Growth Rate (CAGR) of 14.3% during the forecast period.
Published: 2025-04-14
Pages: 179
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 364 million in 2024 and is forecast to a readjusted size of US$ 874 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 141
The global Peptide Nucleic Acid (PNA) market size was US$ 364 million in 2024 and is forecast to a readjusted size of US$ 874 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 102
The global market for Peptide Nucleic Acid (PNA) was valued at US$ 364 million in the year 2024 and is projected to reach a revised size of US$ 874 million by 2031, growing at a CAGR of 14.3% during the forecast period.
Published: 2025-04-14
Pages: 106
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published: 2024-10-25
Pages: 113
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published: 2024-10-25
Pages: 146
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now